Abstract
The coexistence of pituitary microprolactinoma and endometriosis presents a clinical scenario that challenges standard practice in Gynecology and Endocrinology. Although traditionally treated as independent entities, evidence accumulated in recent decades suggests relevant pathophysiological interconnections that directly impact fertility, chronic pelvic pain, and patients’ quality of life. The objective of this report is to describe the management and clinical course of a patient with these conditions. We present the case of a 34-year-old patient who consulted in July 2025 due to a desire for pregnancy, abnormal uterine bleeding, migraines, and decreased libido. Her medical history included obesity and a pituitary adenoma previously treated with cabergoline, which she discontinued more than a year prior at her own request. Early diagnosis and timely treatment of these associated pathologies are of vital importance given our patient’s desire for short-term fertility and her prognosis.
References
Kutlesic R, Kutlesic M, Milosevic-Stevanovic J, Vukomanovic P, Stefanovic M, et al. Prolactin and Hyperprolactinaemia in Endometriosis-Related Infertility: Are There Clinically Significant Connections? J Clin Med. 2024 Oct 1;13(19):5868. doi: 10.3390/jcm13195868
Estole-Casanova LA. A Comprehensive Review of the Efficacy and Safety of Dopamine Agonists as Anti-angiogenic Treatment for Endometriosis-Associated Infertility. Acta Med Philipp. 2024;58(11). doi: 10.47895/amp.vi0.6994
Petersenn S, Fleseriu M, Casanueva FF et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19, 722–740 (2023). https://doi.org/10.1038/s41574-023-00886-5
Shlomo Melmed FF, Casanueva AR, Hoffman DL, Kleinberg VM, Montori JA, et al. Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, Vol 96, (2,) 1 Feb 2011: 273–288. https://doi.org/10.1210/jc.2010-1692
Qi Q, Li Y, Chen Z, Luo Z, Zhou T, et al. Update on the pathogenesis of endometriosis-related infertility based on contemporary evidence. Front Endocrinol (Lausanne). 2025 Mar 10;16:1558271. doi: 10.3389/fendo.2025.1558271
Lamceva J, Uljanovs R, Strumfa I. The Main Theories on the Pathogenesis of Endometriosis. Int J Mol Sci. 2023;24(5):4254. https://www.mdpi.com/1422-0067/24/5/4254
Lee GJ, Porreca F, Navratilova E. Prolactin and pain of endometriosis. Pharmacol Ther. 2023 Jul;247:108435. doi: 10.1016/j.pharmthera.2023.108435
Novella-Maestre E, Carda C, Noguera I, Ruiz-Saurí A, García-Velasco JA, et al. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod. 2009 Mayo;24(5):1025-35. doi: 10.1093/humrep/den499
Monnin N, Fattet AJ, Koscinski I. Endometriosis: Update of Pathophysiology, (Epi) Genetic and Environmental Involvement. Biomedicines. 2023 Mar 22;11(3):978. doi: 10.3390/biomedicines11030978
Esmaeilzadeh S, Mirabi P, Basirat Z, Zeinalzadeh M, Khafri S. Association between endometriosis and hyperprolactinemia in infertile women. Iran J Reprod Med. 2015 Mar;13(3):155-60.
Mirabi P, Alamolhoda SH, Golsorkhtabaramiri M, Namdari M, Esmaeilzadeh S. Prolactin concentration in various stages of endometriosis in infertile women. JBRA Assisted Reproduction. 2019 Aug;23(3):225-229. DOI: 10.5935/1518-0557.20190020.
Lee GJ, Hode V, Georgieva T, Rau J, Dodick DW, et al. Prolactin-induced sensitization of trigeminal nociceptors promotes migraine co-morbidity in endometriosis. Cephalalgia. 2025 Jan;45(1):3331024241313378. doi: 10.1177/03331024241313378
Lee GJ, Hode V, Georgieva T, Rau J, Dodick DW, et al. Prolactin-induced sensitization of trigeminal nociceptors promotes migraine co-morbidity in endometriosis. Cephalalgia. 2025 Jan;45(1):3331024241313378. doi: 10.1177/03331024241313378
Gómez R, Abad A, Delgado F, Tamarit S, Simón C, et al. Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia. Fertil Steril. 2011 Mar 1;95(3):882-8.e1. doi: 10.1016/j.fertnstert.2010.10.024
Esta obra está bajo licencia internacional
